Your Article Summary
Amarna Therapeutics B.V. and TNO announce SVac research and development partnership
b3c newswire, 07/07/09
Dutch biotechnology company Amarna Therapeutics B.V. and the Netherlands Organisation for Applied Scientific Research TNO today announced that they have entered into a collaboration agreement to further develop Amarna's viral gene delivery platform SVac. Under this agreement, TNO will develop novel methods for the manufacture, formulation and testing of viral gene delivery systems such as the SVac platform of Amarna. The collaboration is partly supported by a co-financing initiative aimed at developing innovative technologies.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Watson Receives FTC Clearance for Arrow Acquisition
Watson Pharmaceuticals, 12/03/09
Watson Completes Acquisition of Arrow Group
Watson Pharmaceuticals, 12/03/09
GSK completes extension of strategic collaboration with Aspen
GlaxoSmithKline, 12/02/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President
BayNews International, 12/03/09
GSK Update: GSKs Arepanrix H1N1 pandemic vaccine prequalified by the World Health Organization
GlaxoSmithKline, 12/02/09
Bayer Schering Pharma to collaborate with Micromet on novel approach to cancer therapy
BayNews International, 12/02/09
Article Search
Sponsor


See Latest Articles


